Large Cap High Growth Potential

Results

255

11 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

255 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	AXSM	US$240.66	1.2%	131.6%	US$12.6b	US$276.47	17.5	57.4%	n/a	Pharmaceuticals & Biotech
	GH	US$168.15	17.6%	233.0%	US$22.6b	US$148.58	20.6	58.2%	n/a	Healthcare
	CRDO	US$241.99	-9.7%	158.5%	US$48.3b	US$269.81	95.5	27.5%	n/a	Semiconductors
	NVDA	US$194.83	-0.5%	22.3%	US$4.8t	US$301.62	29.6	22.2%	0.5%	Semiconductors
	LITE	US$728.31	-15.5%	685.2%	US$62.3b	US$1,111.29	129.1	79.1%	n/a	Tech
	MDGL	US$528.63	2.9%	76.9%	US$11.9b	US$678.71	10.8	59.2%	n/a	Pharmaceuticals & Biotech
	MOD	US$230.97	-18.6%	120.9%	US$12.9b	US$340.86	100.4	49.3%	n/a	Capital Goods
	MRVL	US$245.29	-12.8%	226.3%	US$238.0b	US$249.33	84.9	26.0%	0.1%	Semiconductors
	SMTC	US$135.27	-16.6%	201.7%	US$13.7b	US$205.25	11.6	74.6%	n/a	Semiconductors
	NU	US$13.61	9.2%	0.07%	US$65.1b	US$17.82	5.3	20.2%	n/a	Banks
	ARM	US$315.28	-9.3%	103.3%	US$360.4b	US$297.03	372.5	35.8%	n/a	Semiconductors
	BE	US$270.89	-12.4%	1,017.5%	US$82.3b	US$278.85	12771.9	44.9%	n/a	Capital Goods
	AMD	US$518.26	-2.7%	275.8%	US$882.0b	US$508.31	171.3	35.3%	n/a	Semiconductors
	CBRS	US$205.16	21.7%	n/a	US$50.1b	US$291.09	475.5	73.7%	n/a	Semiconductors
	FN	US$499.61	-12.0%	69.6%	US$19.6b	US$749.11	42.5	23.3%	n/a	Tech
	RDDT	US$194.67	23.2%	24.0%	US$38.1b	US$224.92	53.0	25.3%	n/a	Media
	LSCC	US$136.54	-5.3%	162.5%	US$20.0b	US$146.92	941.0	59.3%	n/a	Semiconductors
	APP	US$526.74	18.1%	54.2%	US$189.7b	US$654.47	45.2	21.8%	n/a	Software
	AVGO	US$360.45	-4.9%	31.0%	US$1.8t	US$523.73	58.5	33.5%	0.7%	Semiconductors
	ALAB	US$406.46	2.1%	347.6%	US$73.9b	US$272.47	260.3	30.9%	n/a	Semiconductors
	AXON	US$596.95	34.2%	-25.0%	US$47.9b	US$662.04	233.6	32.8%	n/a	Capital Goods
	MTSI	US$322.26	-17.4%	129.1%	US$26.8b	US$403.00	139.1	39.3%	n/a	Semiconductors
	SITM	US$703.84	1.6%	236.2%	US$19.7b	US$837.50	48.9	83.6%	n/a	Semiconductors
	KRYS	US$375.06	4.2%	162.1%	US$11.0b	US$349.78	49.1	36.6%	n/a	Pharmaceuticals & Biotech

Page 1 of 8